期刊文献+

加替沙星-聚癸二酸酐局部缓释系统预防兔骨髓炎 被引量:4

Gatifloxa-polysebacic anhydride local delivery system for prevention of osteomyelitis in rabbits
下载PDF
导出
摘要 背景:聚酸酐材料具有表面溶蚀性、生物可降解性和释药速率可调性,为人体药物缓释材料,但关于聚癸二酸酐缓释系统的应用至今少有报道。目的:观察加替沙星-聚癸二酸酐局部缓释系统对兔股骨骨髓炎感染模型的预防作用。方法:按Norden法将30只兔制作股骨金黄色葡萄球菌骨髓炎兔模型,分别用加替沙星-聚癸二酸酐缓释制剂和加替沙星进行干预,并与模型组作对照,共分3组,每组10只,观察建模后兔一般情况、解剖学观察、X射线片表现、骨培养及细菌计数、组织学检查。结果与结论:建模后8周,模型组兔建模后,食欲差,皮毛不光滑,体质量减轻,3只兔于3周内死亡,其他7只X射线片上骨膜反应较重,可见小块死骨形成,解剖学检查均可见脓肿形成,骨培养及组织学检查均可见骨髓炎表现;加替沙星组建模后体质量减轻,2只兔于建模后3周内死亡,解剖学检查可见有4只动物有脓肿形成,X射线片上可见8只动物骨膜反应较轻,未见死骨形成,骨培养及组织学检查6只兔有骨髓炎表现;加替沙星-聚癸二酸酐缓释制剂治疗组兔一般情况好,解剖学检查未见异常,X射线片检查、骨培养和细菌计数、组织学检查均未见骨髓炎表现。结果证实,加替沙星-聚癸二酸酐局部缓释制剂预防股骨骨髓炎感染效果较好。 BACKGROUND:Polyanhydride materials characterized as surface corrosion resistance, biodegradability and adjustable release rate have been used as drug delivery materials for the body, but the application of polysebacic anhydride delivery system has been rarely reported. OBJECTIVE:To study the role of gatifloxa-polysebacic anhydride local delivery system in the prevention of osteomyelitis in rabbits. METHODS:According to Norden method, we made Staphylococcus aureus-induced osteomyelitis models in the femur of 30 rabbits. There were three groups in the study, 10 rats in each group. Gatifloxa-polysebacic anhydride local delivery system and gatifloxa were respectively used in comparison with model group. After modeling, general observation, anatomical observation, X-ray examination, bone culture and bacteria counting, and histological examination were performed. RESULTS AND CONCLUSION:After 8 weeks, animals in the model group presented with poor appetite, rough fur, and weight loss. Among these 10 rabbits, 3 rabbits died within 3 weeks, and another 7 rabbits appeared to have severe periosteal reactions on the X-ray films, that is, abscess formation shown in the anatomical examination and visible manifestation of osteomyelitis through bone culture and histological examination. In the gatifloxa group, two rabbits died within 3 weeks, abscess formation was found in four rabbits, and periosteal reactions were mild without bone sequestration. Six of 10 rabbits in the gatifloxa appeared to have manifestation of osteomyelitis. In the delivery system group, the animals had a good general state of health and no abnormality was found in the anatomical examination, X-ray examination, bone culture and bacteria count, and histological examination. These findings indicate that the gatifloxa-polysebacic anhydride local sustained release preparation could effectively prevent osteomyelitis.
出处 《中国组织工程研究》 CAS CSCD 2014年第21期3355-3360,共6页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献16

  • 1Domb AJ,Rock M,Perkin C.Excretion of a radiolabeledanticancer biodegradable polymeric implant from the rabbitbrain.Biomaterials.1995;16(14):1069-1072.
  • 2Norden CW,Shafferm M.Experimental osteomyelitis due toStaphylococcus aureus or Pseudomonas aeruginosa:aradiographic-pathological correlative analysis.Br J Exp Pathol.1980;61(4):451-460.
  • 3Laurence ED,Charle H.Gentamicin-loaded plaster of Parisas a treatment of experimental osteomyelitis in rabbits.ClinOrthop Relat Res.1987:(219):278-282.
  • 4鲁锋,张鸿图,马术友.加替沙星-聚癸二酸酐局部缓释系统的体内释药特性[J].中国组织工程研究,2013,17(29):5351-5356. 被引量:2
  • 5鲁锋,张鸿图,马术友.加替沙星-聚癸二酸酐局部缓释系统的生物相容性[J].中国组织工程研究,2013,17(25):4623-4628. 被引量:2
  • 6Ostermann PA,Seiigson D,Henry SL.Local antibiotic therapyfor severe open fractures.A review of 1085 consecutivecases.J Bone Joint Surg Br.1995:77(1):93-97.
  • 7Grace EJ,Bryoson V.Modern treatment of chronicosteomyelitis with topical detergent antibiotic therapy.SurgGynecol Obstet.1950;91(3):333-342.
  • 8Perry CR,Kitterbusch JK,Rice SH,et al.Antibiotics deliveredby an implantable drug pump;a new application for treatingosteomyelitis.Am J Med.1986;80(6B):222-227.
  • 9陈爱民,侯春林,屠开元.几丁糖庆大霉素药物释放系统的研制及体外释放实验[J].中华骨科杂志,1997,17(9):591-593. 被引量:23
  • 10Kahn DS,Pritzker KP.The pathophysiology of bone infection.Clin Orthop Relat Res.1973;8(96):12-19.

二级参考文献20

  • 1程祝海,张君.加替沙星序贯治疗下呼吸道细菌感染56例疗效观察[J].重庆医学,2006,35(3):258-259. 被引量:1
  • 2李绪春,朱红.单剂量加替沙星口服在Beagle犬体内药代动力学研究[J].中国药业,2006,15(10):6-7. 被引量:4
  • 3侯春林,中国修复重建外科杂志,1996年,10卷,176页
  • 4俞耀庭;张兴栋.生物医用材料[M]{H}天津:天津大学出版社,200012-39.
  • 5Langer R. Biomaterials in drug delivery and tissue engineering:One laboratory's experience[J].{H}Accounts of Chemical Research,2000,(02):94-101.
  • 6Sampath P,Brem H. Implantable slow-release chemotherapeutic polymers for the treatment of malignant brain tumors[J].{H}Cancer Control:Journal of the Moffitt Cancer Center,1998,(02):130-137.
  • 7Cai QX,Zhu KJ,Chen D. Synthesis,characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride P(CBFAS)[J].{H}European Journal of Pharmaceutics and Biopharmaceutics,2003,(02):203-208.
  • 8Berkland C,Kipper MJ,Narasimhan B. Micro- sphere size,precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres[J].J Control ed Release,2004,(01):129-141.
  • 9Stahlberg HJ,Cohler K,Cuil ane M. Effects of gatifloxacin mesylate(GTFX)On the pharmacokinetics of theophyline in heathly young volunteers[J].Antimierob Agents Chemther,1999,(sup A):136.
  • 10Cai QX,Zhu KJ,Chen D. Synthesis,characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride P(CBFAS)[J].Eur J Pharma Biopharms,2003,(02):203-208.

共引文献23

同被引文献58

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部